Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored
Inflammatory bowel disease (IBD) is a complex multifactorial chronic inflammatory disease, that includes Crohn’s disease (CD) and ulcerative colitis (UC), having progressively increasing global incidence. Disturbed intestinal flora has been highlighted as an important feature of IBD and offers promi...
Main Authors: | Mengjie Zhu, Yijie Song, Yu Xu, Hongxi Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/13/11004 |
Similar Items
-
The Gut Microbiota in Inflammatory Bowel Disease
by: Peng Qiu, et al.
Published: (2022-02-01) -
Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease
by: Yongjia Hu, et al.
Published: (2022-12-01) -
Features of Gut Microbiome Associated With Responses to Fecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review
by: Jindong Zhang, et al.
Published: (2022-05-01) -
Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease
by: Namrata Iyer, et al.
Published: (2021-11-01) -
Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection
by: Maria Kulecka, et al.
Published: (2023-07-01)